Home › Funds › RTW INVESTMENTS, LP › NBIX

RTW INVESTMENTS, LP position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

RTW INVESTMENTS, LP reported holding 942,684 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$133.7M, representing 1.35% of its reported portfolio and ranking #28 among its reported holdings. RTW INVESTMENTS, LP has disclosed NBIX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)942.68K sh
Reported value held$133.71M
Portfolio Weight1.35%
First reportedQ2 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's NBIX position evolved

RTW INVESTMENTS, LP first disclosed a stake in NBIX in Q2 2025 at 1,062,072 shares (US$133.5M). The position peaked in Q2 2026 at 1,267,925 shares, worth US$213.7M. Across 6 filings, RTW INVESTMENTS, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 942,684 shares valued at US$133.7M — a reduction of -325,241 shares quarter over quarter.. Notable position changes include a 26% trim in Q3 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.06M $133.49M New
Q3 2025 1.06M $149.09M Hold
Q4 2025 1.06M $150.63M Hold
Q1 2026 1.06M $139.92M Hold
Q2 2026 1.27M $213.69M Add
Q3 2026 942.68K $133.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 28 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has RTW INVESTMENTS, LP held NBIX?

RTW INVESTMENTS, LP has disclosed NBIX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is RTW INVESTMENTS, LP's current position in NBIX?

As of Q3 2026, RTW INVESTMENTS, LP holds 942.68K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $133.71M, representing 1.35% of its reported portfolio and ranking #28.

Has RTW INVESTMENTS, LP been buying or selling NBIX?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP reduced its position in NBIX. The position peaked in Q2 2026 at 1.27M shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Renaissance Technologies, Vestal Point Capital, LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.